Pharma giant announced today that it is buying , a startup developing drugs with applications in obesity treatment, in a transaction valued at up to $1.93 billion.
Lilly did not specify how much of the will be upfront and how much will be contingent on Versanis meeting future milestones tied to clinical progress and sales. Given that Versanis is still an early-stage company, it鈥檚 likely most of the payment will be tied to meeting milestones.
Search less. Close more.
Grow your revenue with all-in-one prospecting solutions powered by the leader in private-company data.
Still, it鈥檚 a big number, especially considering that Oakland-based Versanis was only founded in 2021. That year, the company raised its only known venture round, a $70 million led聽 by and .
Notably, Versanis is one of a number of recently funded startups working on treatments for obesity and to promote weight loss. Using 附近上门 data, we curated a list of nine companies that last raised capital in the past year:
Illustration:
Stay up to date with recent funding rounds, acquisitions, and more with the 附近上门 Daily.
![Illustration of a guy watering plants with a blocked hose - Global [Dom Guzman]](/wp-content/uploads/quarterly-global-3-300x168.jpg)
67.1K Followers